[go: up one dir, main page]

AU6081294A - Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides - Google Patents

Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides

Info

Publication number
AU6081294A
AU6081294A AU60812/94A AU6081294A AU6081294A AU 6081294 A AU6081294 A AU 6081294A AU 60812/94 A AU60812/94 A AU 60812/94A AU 6081294 A AU6081294 A AU 6081294A AU 6081294 A AU6081294 A AU 6081294A
Authority
AU
Australia
Prior art keywords
treatment
pyrimidine nucleosides
toxicity
agent
chemotherapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60812/94A
Other languages
English (en)
Inventor
Michael Kevin Bamat
Reid Warren Von Borstel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro Neuron Inc
Original Assignee
Pro Neuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Neuron Inc filed Critical Pro Neuron Inc
Publication of AU6081294A publication Critical patent/AU6081294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU60812/94A 1993-05-14 1993-12-30 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides Abandoned AU6081294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6138193A 1993-05-14 1993-05-14
US061381 1993-05-14
PCT/US1993/012689 WO1994026761A1 (fr) 1993-05-14 1993-12-30 Traitement de la toxicite des agents chimioterapeutiques et des agents antiviraux avec des nucleosides de pyrimidine acyles

Publications (1)

Publication Number Publication Date
AU6081294A true AU6081294A (en) 1994-12-12

Family

ID=22035423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60812/94A Abandoned AU6081294A (en) 1993-05-14 1993-12-30 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides

Country Status (2)

Country Link
AU (1) AU6081294A (fr)
WO (1) WO1994026761A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5959100A (en) 1996-03-27 1999-09-28 Nexstar Pharmaceuticals, Inc. Pyrimidine nucleosides as therapeutic and diagnostic agents
US5945527A (en) * 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
EP0882734B1 (fr) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag Dérivés de 5'-déoxy-cytidine
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
AU8388198A (en) * 1997-08-21 1999-03-08 Basf Aktiengesellschaft Use of uridine to counter 5-fluorouracil toxicity
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6472378B2 (en) 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
US6020483A (en) * 1998-09-25 2000-02-01 Nexstar Pharmaceuticals, Inc. Nucleoside modifications by palladium catalyzed methods
CN1427722A (zh) 2000-02-18 2003-07-02 希拉生物化学股份有限公司 用核苷类似物治疗或预防黄病毒感染的方法
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US7589077B2 (en) * 2001-05-18 2009-09-15 Rakesh Kumar Antiviral nucleosides
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
CA2729613C (fr) * 2008-03-03 2017-02-07 Tosk, Incorporated Adjuvants pour reduire la toxicite du methotrexate, et procedes d'utilisation
US8329666B2 (en) 2009-04-06 2012-12-11 Eisai Inc. Compositions and methods for treating cancer
ES2593088T3 (es) 2009-04-06 2016-12-05 Otsuka Pharmaceutical Co., Ltd. Derivados de (2'-Desoxi-Ribofuranosil)-1,3,4,7-Tetrahidro-(1,3)Diazepin-2-ona para Tratamiento de Cáncer
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
AU2010234562B2 (en) 2009-04-06 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
PH12014500477A1 (en) 2011-08-30 2024-04-03 Astex Pharmaceuticals Inc Decitabine derivative formulations
AU2016287585B2 (en) 2015-07-02 2020-12-17 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
WO2018035380A1 (fr) 2016-08-17 2018-02-22 Solstice Biologics, Ltd. Constructions polynucléotidiques
EP3645546A4 (fr) 2017-06-30 2021-12-01 Solstice Biologics, Ltd. Auxiliaires de phosphoramidites chiraux et leurs procédés d'utilisation
KR20200035438A (ko) 2017-08-03 2020-04-03 오쓰까 세이야꾸 가부시키가이샤 약물 화합물 및 이의 정제 방법
WO2020036975A1 (fr) * 2018-08-14 2020-02-20 Tosk, Inc. Méthodes et compositions pour réduire la toxicité induite par le fluorouracile
EP3836941A4 (fr) 2018-08-14 2022-05-18 Tosk, Inc. Procédés et compositions pour le traitement de la mucosite
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
AU2021306230A1 (en) 2020-07-07 2023-03-02 Tosk, Inc. Uridine phosphorylase inhibitors to treat or prevent pulmonary disease
AU2022244240A1 (en) * 2021-03-26 2023-10-05 The Cleveland Clinic Foundation Treatment of rna virus infection with a cytidine deaminase inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1297398A (fr) * 1969-08-06 1972-11-22
EP0151189B1 (fr) * 1983-07-20 1990-01-31 Teijin Limited Agent antineoplastique
JPS60174797A (ja) * 1984-02-21 1985-09-09 Funai Corp Ν−アロイルチミジン誘導体ならびに抗腫瘍活性物質の毒性低下剤
US4874602A (en) * 1988-02-22 1989-10-17 Paul Calabresi Reduction of the severity 3'-azido-3'-deoxythymidine-induced anemia using benzylacyclouridine
US4950466A (en) * 1988-06-22 1990-08-21 Paul Calabresi Reduction of the severity of 3'-azido-3'-deoxythymidine-induced anemia using a combination of benzylacyclouridine and dipyridamole
US5077290A (en) * 1990-10-11 1991-12-31 Merck & Co., Inc. Morpholine derivatives compositions and use

Also Published As

Publication number Publication date
WO1994026761A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
AU6081294A (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
NZ262797A (en) Polycyclic guanine derivatives, purine and pyrimidine precursors; medicaments
AU3363499A (en) Nucleosides with antiviral and anticancer activity
IL110992A0 (en) n-substituted 5'-deoxy adenosine derivatives and pharmaceutical compositions containing them
EP0831849A4 (fr) Procedes de reduction de la toxicite d'agents chimiotherapeutiques et antiviraux avec des nucleosides de pyrimide acyles
PL305355A1 (en) Novel derivatives of 4-aryl aminibenzopirane and pharmaceutic agent
AU8448491A (en) Antiviral compounds and antihypertensive compounds
GB9218810D0 (en) Antiviral pyrimidine nucleosides
AU4134793A (en) 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
AU661379B2 (en) Method of reducing or preventing toxicity associated with antiretroviral therapy
HU9403021D0 (en) 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo[3,2-d]pyrimidine and pharmaceutical compositions containing them
IL102407A0 (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
AU5883794A (en) Diazepin derivatives and antiviral compositions
AU655351B2 (en) BU-4641V, an antibacterial, antiviral and antitumor antibiotic
GB8902041D0 (en) Antiviral agent and novel nucleoside
HK1010143A (en) Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
AU4879496A (en) Antiviral combinations of bch-189 and ritonavir
SG48806A1 (en) Method of combating acyclovir-resistant herpes simplex viral infections
AU5232493A (en) Antiviral antibiotic BU-4724U and preparation thereof
AU5999494A (en) Wide spectrum antiviral chemotherapeutic agent and use thereof
AU4228993A (en) 6-pyridyl substituted pyrimidine derivatives and their use as antiviral agents
AU7706191A (en) Synthesis of nucleotide and nucleoside derivatives
HU9200115D0 (en) Materials of antitumor activity with diminished toxicity by aid of citostatic materials and xantogenates
AU5232393A (en) Antiviral antibiotic BU-4628V and preparation thereof
ZA907701B (en) 6-substituted acyclopyrimidine nucleoside derivatives and antiviral agent containing the same as active ingredient thereof